From neurobiology to treatment: Progress against addiction

Nature Neuroscience

Volumn 5, Issue 11s, 2002, Pages 1076-1079

  Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; CLONIDINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVACETYLMETHADOL; METHADONE; NALTREXONE; OPIATE ANTAGONIST;

ADDICTION; DRUG ACTIVITY; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG WITHDRAWAL; HUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RELAPSE; REVIEW;

ANIMALS; BRAIN CHEMISTRY; HUMANS; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROTRANSMITTER; REWARD; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 0036830646     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn945     Document Type: Article

References (28)

1. Nestler, E. J. Molecular basis of neural plasticity underlying addiction. Nat. Rev. Neurosci. 2, 119-128 (2001).
2. Koob, G. F., Sanna, P. P. & Bloom, F. E. Neuroscience of addiction. Neuron 21, 467-476 (1998).
3. Wise, R. A. Drug-activation of brain reward pathways. Drug Alcohol Depend. 51, 13-22 (1998).
4. Everitt, B. J. & Wolf, M. E. Psychomotor stimulant addiction: a neural systems perspective. J. Neurosci. 22, 3312-3320 (2002).
5. O'Brien, C. P. A range of research-based pharmacotherapies for addiction. Science 278, 66-70 (1997).
6. Aghajanian, G. K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276, 186-188 (1978).
7. Gold, M. S., Redmond, D. E. Jr. & Kleber, H. D. Clonidine blocks acute opiate-withdrawal symptoms. Lancet 2, 599-602 (1978).
8. Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F. & Rosenheck, R. A. Veterans Affairs Naltrexone Cooperative Study 425 Group. Naltrexone in the treatment of alcohol dependence. N. Engl. J. Med. 345, 1734-1739 (2001).
9. Kantak, K. M., Collins, S. L., Bond, J. & Fox, B. S. Time course of changes in cocaine self-administration behavior in rats during immunization with the cocaine vaccine IPC-1010. Psychopharmacology 153, 334-340 (2001).
10. Cohen, P. J. Immunization for prevention and treatment of cocaine abuse: legal and ethical implications. Drug Alcohol Depend. 48, 167-174 (1997).
11. National Consensus Development Panel. Effective medical treatment of opiate addiction. JAMA 280, 1936-1943 (1998).
12. Kreek, M. J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann. NY Acad. Sci. 909, 186-216 (2000).
13. Ling, W. et al. Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 93, 475-486 (1998).
14. Silagy, C., Lancaster, T., Stead, L., Mant, D. & Fowler, G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 3, CD000146 (2001).
15. Pulvirenti, L. & Koob, G. F. Dopamine receptor agonists, partial agonists and psychostimulant addiction. Trends Pharmacol. Sci. 15, 374-379 (1994).
16. Self, D. W., Barnhart, W. J., Lehman, D. A. & Nestler, E. J. Opposite modulation of cocaine-seeking behavior by D1-like and D2-like dopamine receptor agonists. Science 271, 1586-1589 (1996).
17. Hyman, S. E. & Malenka, R. C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2, 695-703 (2001).
18. Carlezon, W. A. Jr., Haile, C. N., Neve, R. & Nestler, E. J. Distinct sites of opiate reward and aversion within the midbrain identified using a herpes simplex virus (HSV) vector expressing GluR1. J. Neurosci. 20, RC62 (2000).
19. Nicola, S. M., Surmeier, J. & Malenka, R. C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23, 185-215 (2000).
20. Cornish, J. L. & Kalivas, P. W. Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J. Addictive Dis. 20, 43-54 (2001).
21. Ungless, M. A., Whistler, J. L., Malenka, R. C. & Bonci, A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature, 411, 583-587 (2001).
22. Self, D. W. Where's the excitement in psychostimulant sensitization? Neuropsycho pharmacology 26, 14-17 (2002).
23. Hutcheson, D. M., Everitt, B. J., Robbins, T. W. & Dickinson, A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat. Neurosci. 4, 943-947 (2001).
24. Shalev, U., Morales, M., Hope, B., Yap, J. & Shaham, Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology 156, 98-107 (2001).
25. Shaham, Y., Erb, S. & Stewart, J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33, 13-33 (2000).
26. Bohn, L. M., Gainetdinov, R. R., Lin, F. T., Lefkowitz, R. J. & Caron, M. G. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723 (2000).
27. Potenza, M. N. & Nestler, E. J. Effects of RGS proteins on the functional response of the μ opioid receptor in a melanophore-based assay. J. Pharmacol. Exp. Ther. 291, 482-491 (1999).
28. Nestler, E. J., Barrot, M. & Self, S. W. AFosB: a molecular switch for addiction. Proc. Natl. Acad. Sci. USA 98, 11042-11046 (2001).